Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “multiple sclerosis”

Assessing the Effects of Ongoing Ocrelizumab (OCR) Therapy on Fatigue and Cognition in Veterans With Multiple SclerosisNot Yet Recruiting
NCT07181811NAUpdated Sep 18, 2025
Sponsor: Anza Memon
Multiple Sclerosis
United States
Prospective Evaluation of Sequencing From antiCD-20 Therapies to OzanimodRecruiting
NCT06529406Phase 4Updated Sep 18, 2025
Sponsor: University of Colorado, Denver
Relapsing Multiple Sclerosis
United States
Understanding the 'Durable Effect' Concept of B-cell Modulating TherapiesRecruiting
NCT06586177N/AUpdated Sep 18, 2025
Sponsor: Heinrich-Heine University, Duesseldorf
Relapsing-remitting Multiple Sclerosis
Germany
Lifestyle Physical Activity Intervention for Persons Newly Diagnosed With Multiple SclerosisActive Not Recruiting
NCT06355804NAUpdated Sep 17, 2025
Sponsor: University of Illinois at Chicago
Multiple Sclerosis
United States
Dose-finding Study for SAR442168 in Relapsing Multiple SclerosisCompleted
NCT03889639Phase 2Updated Sep 17, 2025
Sponsor: Sanofi
Relapsing Multiple Sclerosis
United States, Canada, Czechia, Estonia, France +5 more
Comparing the Acute Effects of Different Exercise Approaches in Patients With Multiple SclerosisCompleted
NCT06721416NAUpdated Sep 17, 2025
Sponsor: Acibadem University
Multiple Sclerosis
Turkey (Türkiye)
Impact of a Tele-rehabilitation Program on People With Multiple SclerosisActive Not Recruiting
NCT07178834NAUpdated Sep 17, 2025
Sponsor: Multiple Sclerosis Center of Catalonia
Multiple Sclerosis
Spain
Study of Drug-drug Interaction of the Effects of Gemfibrozil and Rifampicin on SAR442168 in Healthy Adult SubjectsCompleted
NCT06064539Phase 1Updated Sep 17, 2025
Sponsor: Sanofi
Multiple Sclerosis
United States
Physiological Effects of N-Acetyl Cysteine in Patients With Multiple SclerosisEnrolling By Invitation
NCT03032601NAUpdated Sep 17, 2025
Sponsor: Thomas Jefferson University
Multiple Sclerosis
United States
Assessment of Clemastine Fumarate as a Remyelinating Agent in Multiple SclerosisCompleted
NCT02040298Phase 2Updated Sep 17, 2025
Sponsor: University of California, San Francisco
Multiple Sclerosis, Relapsing-Remitting
United States
Oct-A and Perimetry in Multiple SclerosisNot Yet Recruiting
NCT07175324N/AUpdated Sep 16, 2025
Sponsor: Assiut University
Multiple Sclerosis
Montpellier PROspective Cohort in Relapsing Remitting Multiple Sclerosis Using Imaging and SerologicRecruiting
NCT05962177NAUpdated Sep 16, 2025
Sponsor: University Hospital, Montpellier
Multiple Sclerosis
France
A Clinical Trial to Assess Pharmacokinetic Profiles, Safety and Tolerability of IVL3004 and IVL4002 in Healthy Male Subjects.Recruiting
NCT05620940Phase 1Updated Sep 15, 2025
Sponsor: Inventage Lab., Inc.
Opioid Dependence · Alcohol Dependence · Multiple Sclerosis
Australia
Use of Stromal Vascular Fraction in Multiple SclerosisSuspended
NCT03461419NAUpdated Sep 12, 2025
Sponsor: Healeon Medical Inc
Multiple Sclerosis · Autoimmune
United States, Honduras
Efficacy of Diet on Quality of Life in Multiple SclerosisActive Not Recruiting
NCT05007483NAUpdated Sep 12, 2025
Sponsor: Terry L. Wahls
Multiple Sclerosis, Relapsing-Remitting
United States
A Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 (Peginterferon Beta-1a) in Pediatric Participants for the Treatment of Relapsing-Remitting Multiple SclerosisActive Not Recruiting
NCT03958877Phase 3Updated Sep 11, 2025
Sponsor: Biogen
Multiple Sclerosis, Relapsing-Remitting
United States, Argentina, Australia, Belgium, Bulgaria +17 more
A Real-world Study About the Impact of Siponimod Treatment on Secondary Progressive Multiple Sclerosis Patients in RussiaCompleted
NCT07168694N/AUpdated Sep 11, 2025
Sponsor: Novartis Pharmaceuticals
Secondary Progressive Multiple Sclerosis
United States
SPINCOMS Biomarker StudyCompleted
NCT04496830N/AUpdated Sep 11, 2025
Sponsor: Washington University School of Medicine
Multiple Sclerosis
United States
Neurophysiological Effects of Transcutaneous Electrical Nerve Stimulation in Persons With MSNot Yet Recruiting
NCT06432686NAUpdated Sep 10, 2025
Sponsor: University Medical Center Groningen
Fatigue · Walking, Difficulty · Multiple Sclerosis
Evaluation of the Impact of Multiple Sclerosis and Its Treatments on Women FertilityCompleted
NCT07164924N/AUpdated Sep 10, 2025
Sponsor: University Hospital, Clermont-Ferrand
Multiple Sclerosis · Neuromyelitis Optica Spectrum Disorders · Fertility
France, Martinique
Vancomycin Study in Multiple Sclerosis (MS)Recruiting
NCT05539729Phase 1Updated Sep 10, 2025
Sponsor: Icahn School of Medicine at Mount Sinai
Multiple Sclerosis
United States
VR-Based Optokinetic Stimulation in Multiple SclerosisNot Yet Recruiting
NCT07150520NAUpdated Sep 9, 2025
Sponsor: Avrasya University
Multiple Sclerosis
Evaluation of the Safety and Efficacy of a Full-Body Electrostimulation Garment for Individuals With Neurological and Neuromuscular Conditions That Cause Spasticity, Hyperreflexia, and PainRecruiting
NCT07132775NAUpdated Sep 9, 2025
Sponsor: Shirley Ryan AbilityLab
Multiple Sclerosis · Fibromyalgia · Neurologic Disorder · Neuromuscular Disorders
United States
Effects of tDCS and Cognitive Rehabilitation on Cognition and Neural Plasticity in MS PatientsCompleted
NCT07160218NAUpdated Sep 8, 2025
Sponsor: Shahid Beheshti University of Medical Sciences
Multiple Sclerosis
Iran
A Study Investigating the Utilization, Effectiveness and Quality of Life in Clinical Practice in Germany for Participants With Relapsing-remitting Multiple Sclerosis Treated With Ozanimod (Zeposia®)Completed
NCT05335031N/AUpdated Sep 8, 2025
Sponsor: Bristol-Myers Squibb
Multiple Sclerosis, Relapsing-Remitting
Germany

Previous page Next page